Table 1.
Patient Characteristics, Chronic Liver Disease Etiologies, Waiting List Complications, Death or Removal from Waiting List, Transplant Status, and Sarcopenia Status by Race
| White n=34 n (%)a |
Asian n=50 n (%) |
NHOPI n=18 n (%) |
P-value | |
|---|---|---|---|---|
| Female | 14 (41) | 23 (46) | 8 (44) | .91 |
| Mean Age (SD)a | 56.1 (8) | 56.8 (9) | 53.2 (11) | .50 |
| Obesity, BMI≥30 | 9 (27) | 14 (28) | 14 (78) | <.001 |
| Ascites | 26 (77) | 34 (68) | 13 (72) | .70 |
| Hepatic encephalopathy | 26 (77) | 25 (50) | 11 (61) | .051 |
| Variceal bleeding | 11 (32) | 13 (26) | 3 (17) | .47 |
| Mean MELD (SD)a | 8.9 (8) | 17.5 (8) | 16.9 (8) | .70 |
| Hepatitis B | 1 (3) | 11 (22) | 4 (22) | .044 |
| Hepatitis C | 15 (44) | 15 (30) | 6 (33) | .41 |
| Alcoholic liver disease | 16 (47) | 9 (18) | 3 (17) | .007 |
| NASH | 2 (6) | 10 (20) | 3 (17) | .188 |
| Liver cancer | 9 (27) | 18 (36) | 8 (44) | .40 |
| Significant waiting list event | 9 (27) | 6 (12) | 4 (22) | .23 |
| Death or removal on waiting list | 14 (41) | 16 (32) | 5 (28) | .56 |
| Transplanted | 14 (41) | 31 (62) | 12 (67) | .101 |
| Sarcopenia by SMI at L3 | 23 (70), n=33c | 30 (60) | 3 (17) | <.001b |
| Sarcopenia by PMI at umbilicus | 2 (8), n=24c | 6 (15), n=39c | 2 (15), n=13c | .70 |
Abbreviations: NHOPI, Native Hawaiian and Other Pacific Islander; SD, Standard deviation; BMI, Body mass index; MELD, Model for End-Stage Liver Disease; NASH, Non-alcoholic steatohepatitis; SMI, Skeletal muscle index; PMI, Psoas muscle index.
a
Count and percent presented except where denoted by the asterisk.
b
Subgroup analysis showed there was no difference between whites and Asians (P=.49).
c
n is number of patients. These differences are based on the availability of cross-sectional images.